CDKN2A and Miyoshi myopathy: Mutations/copy-number loss of tumor suppressor genes, such as cyclin-dependent kinase inhibitor 2A (CDKN2A), neurofibromin 2 (NF2), and BRCA1 associated protein 1 (BAP1), are the most frequent genetic alterations in MM [14,15,16].